Hann. Muenden, Germany

Tobias Wuerschmidt

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tobias Wuerschmidt in Extracorporeal Blood Treatment

Introduction

Tobias Wuerschmidt is a notable inventor based in Hann. Muenden, Germany, recognized for his contributions to medical technology. With a total of two patents under his name, his work focuses primarily on innovations in extracorporeal blood treatment devices, aiming to enhance efficiency and accuracy in medical procedures.

Latest Patents

Wuerschmidt's latest patents include advancements in pressure measurement and automatic priming for extracorporeal blood treatment devices.

1. **Pressure Measurement in the Extracorporeal Blood Circuit**: This patent presents a device and method for calibrating a first pressure sensor through a series of steps involving recursive analysis. The method incorporates constant internal pressure and temperature to deliver precise calibration of the pressure sensor before and during active use.

2. **Automatic Priming of an Extracorporeal Blood Treatment Device**: This innovation details a method for automatically priming such devices using a push-pull mechanism. It includes a control unit designed to manage liquid delivery and pressure control, ensuring that air is effectively pushed and pulled during the priming process to facilitate fluid transfer through the dialyzer.

Career Highlights

Wuerschmidt currently works at B. Braun Avitum AG, a company known for its commitment to advancing medical technology and providing innovative healthcare solutions. His role involves not only the development of his patents but also contributing to the overall mission of improving patient care through enhanced medical devices.

Collaborations

Throughout his career, Wuerschmidt has collaborated with several experts in the field, including colleagues Joana Sophie Schiller and Fakher Ahmed. These partnerships have fostered a creative environment, leading to the development of groundbreaking technologies in extracorporeal blood treatment.

Conclusion

Tobias Wuerschmidt is a significant force in medical innovation, particularly in the realm of extracorporeal blood treatment. Through his patents and collaborative efforts, he continues to push the boundaries of technology and improve healthcare solutions, making a lasting impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…